This November the American Heart Association held their annual conference in Chicago. Over 10,000 clinicians and researchers in attendance. Sessions focused on the latest insights and below we’ve listed [...]
The American Heart Association’s (AHA) 2024 Scientific Session was held in Chicago in November. This is one of the premier scientific meetings of the year with over 10,000 clinicians [...]
New research from the Family Heart Foundation shows access to PCSK9 inhibitors (PCSK9i) has slightly improved, but there are still major barriers to these lifesaving drugs. What [...]
Access to Prescribed PCSK9 Inhibitors Remains a Significant Barrier Leaving Patients at Risk for Heart Attacks and Strokes Family Heart Foundation Research Shows Insurance Coverage is an [...]
When it comes to the diagnosis and treatment of familial hypercholesterolemia (FH) and elevated lipoprotein(a), or Lp(a), there are still so many unanswered questions. What we have learned from our research is impacting [...]
September is National Cholesterol Education Month, and that makes it the perfect time to shine a light on cholesterol management in America. Family Heart Foundation research shows [...]
Breaking Down the Latest Family Heart Foundation Research on HoFH in America A new study from the Family Heart Foundation is the largest look at how individuals with homozygous familial hypercholesterolemia (HoFH) are being treated [...]
VIEW ARTICLE Published in JAHA, Study Shows Delayed Diagnosis of HoFH, a Rare Disease, Leads to Premature Cardiovascular Disease PASADENA, Calif., May 2, 2023 – A new study [...]
Family Heart Foundation Research Finds High-Risk Americans Who Do Not Maintain Guideline Recommended LDL-C Targets Have 44% Higher Rate of Cardiovascular Events Findings Based on Real-World Analysis to be Presented [...]
Lipoprotein(a), also known as Lp(a), is an important genetic factor that can increase the risk of developing atherosclerosis (hardening of the arteries) and cardiac events, like heart attacks and strokes. [...]
Copyright © - 2024 All Rights Reserved Family Heart Foundation
Early diagnosis and treatment can mean years, even decades of life for someone with impacted by familial hypercholesterolemia (FH) and lipoprotein(a), also known as Lp(a).
Yet a majority of people with these inherited disorders haven’t even been diagnosed.
Your gift allows us to continue to engage the research, advocacy, and education that helps individuals with FH, HoFH, or elevated Lp(a) get the vital medical care that they need.
